About Oxipit
Oxipit is a leader in AI-driven medical imaging, founded in 2017 by experts in medicine and data science. Since 2026, the company has been part of Sectra, one of the world's leading providers of enterprise imaging and healthcare IT. Oxipit develops clinically validated radiology AI solutions that help healthcare providers improve efficiency, support diagnostic workflows, and focus on patient care. The company's flagship innovation, ChestLink, launched in April 2022 as the world's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting, capable of identifying normal studies with 99.9% sensitivity and automating up to 40% of cases. What started with chest X-ray AI has expanded into three comprehensive suites: the CXR Suite, CT Suite, and MSK Suite, covering chest X-ray, chest CT, and musculoskeletal imaging. In 2019, ChestEye received CE certification for generating preliminary reports for 75 chest X-ray findings. Each suite is designed to streamline radiology workflows, reduce oversights, and support confident decision-making. Oxipit's solutions integrate seamlessly into existing PACS and healthcare IT systems through partnerships with leading AI marketplaces and imaging platform providers. Trusted by healthcare providers worldwide, from major hospitals to remote clinics, Oxipit continues to advance AI-powered diagnostics, strengthening Sectra's vision for integrated and AI-enabled diagnostic workflows.
Mission & Story
Mission
Empowering equitable, precise healthcare, transform diagnosis, and improve patient care worldwide
Founding Story
Oxipit's journey began in 2017 at an innovative AI hackathon, where a team of medical and data science experts united to address a growing global challenge: the shortage of radiologists. Driven by a shared vision to improve patient care, they quickly developed a prototype that would evolve into Oxipit ChestEye, an AI solution designed to improve efficiency in medical imaging workflows.
Clinical Focus
Medical conditions and clinical areas addressed by Oxipit.
Who It Serves
Milestones & Awards
Recent Milestones
Acquired by Sectra in March 2026. Launched CT Eye and MSK Eye in February 2026, expanding beyond chest X-ray. Selected by German Medical Institute and Diagnostikum Group (Austria) in 2025-2026. Demonstrated solutions at European Congress of Radiology (ECR) 2026.
Awards & Recognition
World's first CE Class IIb-certified autonomous AI application for healthy chest X-ray reporting. World's first autonomous AI for radiology reporting.
Key Partnerships
Social & Media
Latest Updates
Diagnostic confidence at speed: how FIDI uses Oxipit AI through CARPL in emergency care
Diagnostikum Group selects Oxipit CXR Suite after rigorous multi-vendor evaluation
UKIO 2025 reflections: autonomous AI is ready. The question is — are we ready to use it?
Oxipit welcomes new strategic advisor
Oxipit enters agreement to be acquired by Sectra to scale autonomous AI in radiology
Company Details
- Founded
- 2017
- Headquarters
- Vilnius, Lithuania
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
AEYE Health
11-50 employees
AEYE Health provides FDA-cleared autonomous AI diagnostic screening for diabetic retinopathy and other eye diseases using retinal images. Their point-of-care solution enables primary care physicians to screen and diagnose patients instantly with portable or desktop cameras.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.